ArticleHemaSphere2024

Prophylactic tocilizumab reduces the incidence of cytokine release syndrome in relapsed/refractory myeloma patients treated with teclistamab: Implications for outpatient step-up dosing.

Charlotte L B M Korst et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.